Medtronic (MDT) Current Deferred Revenue (2025 - 2026)
Medtronic (MDT) posted Current Deferred Revenue of $249.0 million for Q2 2026, down 12.01% sequentially from $283.0 million in Q1 2026, and down 36.32% YoY from $391.0 million in Q2 2025.
Medtronic (MDT) Current Deferred Revenue (2025 - 2026) Analysis & Trends
Medtronic has reported Current Deferred Revenue for 2 years, with the latest figure at $249.0 million in Q2 2026.
- Quarterly Current Deferred Revenue fell 36.32% year-over-year to $249.0 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $249.0 million (down 36.32% YoY) and the FY2026 annual result came in at $249.0 million, down 36.32% from the prior year.
- Current Deferred Revenue eased to $249.0 million in Q2 2026 per MDT's latest filing, from $283.0 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $391.0 million in Q2 2025 and troughed at $249.0 million in Q2 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.42 Bn | 19.01 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 24, 2026 | 249.00 Mn |
| Jan 23, 2026 | 283.00 Mn |
| Oct 24, 2025 | 318.00 Mn |
| Jul 25, 2025 | 355.00 Mn |
| Apr 25, 2025 | 391.00 Mn |